(Press-News.org) New Haven, CT — The first long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results — long-lasting with high survival rates — researchers report. First author Mario Sznol, M.D., professor of medical oncology at Yale Cancer Center, is presenting the updated data at the 2014 annual conference of the American Society of Clinical Oncology (ASCO) in Chicago.
Sznol, clinical research leader of the melanoma research program at Yale Cancer Center, was the senior author on the original study of combination immunotherapy that was first published in the New England Journal of Medicine and presented at ASCO in 2013. Jedd Wolchok, M.D., of Memorial Sloan Kettering Cancer Center was first author of the earlier study, and senior author of this updated research.
The trial evaluated the safety and activity of the combination regimen of nivolumab (anti-PD-1), an investigational PD-1 immune checkpoint inhibitor, and ipilimumab (anti-CTLA-4; Yervoy), given either concurrently or sequentially, to patients with advanced melanoma whose disease progressed after prior treatment. The one-year overall survival rate was 94% and the two-year rate was 88%.
"The treatment of advanced melanoma has changed dramatically in the last few years, but there continues to be a need to increase the number of patients who experience a long-term survival benefit," Sznol said. "While these are phase 1b data, the duration of response and one- and two-year survival rates observed with the combination regimen of nivolumab and Yervoy are very encouraging and support the rationale for the ongoing, late-stage trials of this combination regimen."
CTLA-4 and PD-1 are targets for cancer immunotherapy because they are shut down the immune system's ability to respond to attack tumors. Antibodies blocking CTLA-4 and PD-1 enable a strong immune response against cancer by removing the brakes from the immune system. Nivolumab targets the PD-1 receptor on the surface of T-cells, and ipilimumab targets CTLA-4 receptors. Both are manufactured by Bristol-Myers Squibb, which sponsored the study with Ono Pharmaceutical Company, Ltd.
INFORMATION:
Other authors are Harriet Kluger, M.D., Kathleen Reed, Matthew Burke, and Anne Caldwell of Yale School of Medicine and Yale Cancer Center; Margaret Callahan. M.D., Michael Postow, M.D., Naiyer Rizvi, M.D., Alexander Lesokhin, M.D., Neil Segal, M.D., Charlotte Ariyan, M.D., Ruth-Ann Gordon, Stephanie Kronenberg, and Blessing Agunwamba of Memorial Sloan-Kettering Cancer Center; Xiaoling Zhang of Dako North America; Israel Lowy, M.D., Hector David Inzunza, M.D., William Feely, Christine Horak, Quan Hong, Alan Korman, John Wiggington, M.D., and Ashok Gupta, M.D., of Bristol-Myers Squibb; Michael Atkins of Georgetown-Lombardi Comprehensive Cancer Center; and John Kirkwood of the University of Pittsburgh Medical Center.
Yale Cancer Center: http://yalecancercenter.org/index.aspx
Smilow Cancer Hospital at Yale-New Haven: http://www.ynhh.org/smilow-cancer-hospital/default.aspx
Long-term results encouraging for combination immunotherapy for advanced melanoma
The first long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results
2014-06-02
ELSE PRESS RELEASES FROM THIS DATE:
Does your stomach bacteria protect you from obesity?
2014-06-02
The germ Helicobacter pylori is the cause of most stomach ulcers, but new research in Alimentary Pharmacology & Therapeutics suggests that treating the bacteria is linked to weight gain.
It is estimated that 50% of the global population may be infected with H. pylori; however, only 20% of infected people experience symptoms. New evidence suggests that patients treated for the infection developed significant weight gain compared to subjects with untreated H. pylori colonization.
By reviewing data taken from forty-nine studies with data from ten European countries, Japan, ...
Britain's urban rivers cleanest in 20 years
2014-06-02
Scientists from Cardiff University have found that Britain's urban rivers are the cleanest they've been in over two decades.
The 21-year study of over 2300 rivers measured the presence of clean-river invertebrates - a yardstick for river health – which during the days of heavy industry and poor sewage treatment had declined considerably, but now appear to be making a comeback.
Although climate change has warmed British rivers by around 1-2 degrees over recent decades, the findings suggest that improved pollution control has managed to offset its damaging effects on ...
Cystic fibrosis and diabetes link explained
2014-06-02
Many people with cystic fibrosis develop diabetes. The reasons for this have been largely unknown, but now researchers at Lund University in Sweden and Karolinska institutet have identified a molecular mechanism that contributes to the raised diabetes risk.
"The increased risk of diabetes has previously been explained by the fact that cystic fibrosis causes damage to the pancreas, where the blood-sugar regulating hormone insulin is produced. We are the first research group to show that the mutated gene that causes cystic fibrosis also plays an important role in the release ...
Ice Storm Project and maternal stress
2014-06-02
Montreal, June 2, 2014 - A new study finds a link between prenatal maternal stress (PNMS) and the development of symptoms of asthma and autism in children.
A team of scientists from The Douglas Mental Health University Institute and from McGill University has been studying women who were pregnant during the January 1998 Quebec ice storm since June of that year and observing effects of their stress on their children's development (Project Ice Storm).The team examined the degree to which the mothers' objective degree of hardship from the storm and their subjective degree ...
Blunting rice disease
2014-06-02
A fungus that kills an estimated 30 percent of the world's rice crop may finally have met its match, thanks to a research discovery made by scientists at the University of Delaware and the University of California at Davis.
The research team, led by Harsh Bais, associate professor of plant and soil sciences in UD's College of Agriculture and Natural Resources, has identified a naturally occurring microbe living right in the soil around rice plants — Pseudomonas chlororaphis EA105 — that inhibits the devastating fungus known as rice blast. What's more, the beneficial soil ...
Obese, older, Caucasian women on dialysis most at risk for rare, deadly condition
2014-06-02
AUGUSTA, Ga. – Obese, Caucasian females over age 50 with diabetes and on dialysis because their kidneys have failed are among those at highest risk for the rare and deadly condition calciphylaxis, according to an analysis of the United States Renal Data System.
Calciphylaxis occurs when calcium and phosphorus bind to form a biological cement that blocks and inflames small blood vessels, putting patients at risk for major infection and skin ulcers as well as patches of dying skin, said Dr. Lu Huber, nephrologist at the Medical College of Georgia at Georgia Regents University.
"It's ...
Why inflammation leads to a leaky blood-brain barrier: MicroRNA-155
2014-06-02
Until now, scientists have not known exactly how inflammation weakens the Blood-Brain Barrier, allowing toxins and other molecules access to the brain. A new research report appearing in the June 2014 issue of The FASEB Journal solves this mystery by showing that a molecule, called "microRNA-155," is responsible for cleaving epithelial cells to create microscopic gaps that let material through. Not only does this discovery help explain the molecular underpinnings of diseases like multiple sclerosis, but it also opens an entirely new avenue for developing therapies that ...
'Healthy' component of red wine, resveratrol, causes pancreatic abnormalities in fetuses
2014-06-02
Here's more evidence that pregnant women should be careful about what they eat and drink: A new research report appearing in the June 2014 issue of The FASEB Journal shows that when taken during pregnancy, resveratrol supplements led to developmental abnormalities in the fetal pancreas. This study has direct relevance to human health--Resveratrol is widely used for its recognized health benefits, and is readily available over the counter.
"The important message in this study is that women should be very careful about what they consume while pregnant, and they should not ...
New therapies harness power of the immune system against cancer
2014-06-02
CHICAGO – New research on innovative immunotherapies for advanced or high-risk melanoma and cervical cancer were presented today at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO). These treatments – used alone or in combination – fight cancer by activating and amplifying the body's immune response to the disease.
The new studies find high activity with investigative drugs for advanced melanoma, and show for the first time that ipilimumab, a treatment already approved for advanced melanoma, can substantially decrease the risk of melanoma ...
Doing more with less; in cellulo structure determinations
2014-06-02
Anyone involved in macromolecular crystallography will know that for many years scientists have had to rely on a multi-stage process utilizing protein, usually expressed in engineered cells, which is then extracted and purified before crystallization in vitro and finally prepared for analysis.
As a counter to this time-consuming and substantial scientific effort, there are a number of examples of protein crystallization events occurring in vivo, with next to no human input. In a case presented in a recent paper an insect virus exploits the phenomenon as part of its life ...
LAST 30 PRESS RELEASES:
Fat tissue around the heart may contribute to greater heart injury after a heart attack
Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America
Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression
Cartilaginous cells regulate growth and blood vessel formation in bones
Plant hormone allows lifelong control of proteins in living animal for first time
Swedish freshwater bacteria give new insights into bacterial evolution
Global measures consistently underestimate food insecurity; one in five who suffer from hunger may go uncounted
Hidden patterns of isolation and segregation found in all American cities
FDA drug trials exclude a widening slice of Americans
Sea reptile’s tooth shows that mosasaurs could live in freshwater
Pure bred: New stem cell medium only has canine components
Largest study of its kind highlights benefits – and risks – of plant-based diets in children
Synergistic effects of single-crystal HfB2 nanorods: Simultaneous enhancement of mechanical properties and ablation resistance
Mysterious X-ray variability of the strongly magnetized neutron star NGC 7793 P13
The key to increasing patients’ advance care medical planning may be automatic patient outreach
Palaeontology: Ancient tooth suggests ocean predator could hunt in rivers
Polar bears may be adapting to survive warmer climates, says study
Canadian wildfire smoke worsened pediatric asthma in US Northeast: UVM study
New UBCO research challenges traditional teen suicide prevention models
Diversity language in US medical research agency grants declined 25% since 2024
Concern over growing use of AI chatbots to stave off loneliness
Biomedical authors often call a reference “recent” — even when it is decades old, analysis shows
The Lancet: New single dose oral treatment for gonorrhoea effectively combats drug-resistant infections, trial finds
Proton therapy shows survival benefit in Phase III trial for patients with head and neck cancers
Blood test reveals prognosis after cardiac arrest
UBCO study finds microdosing can temporarily improve mood, creativity
An ECOG-ACRIN imaging study solves a long-standing gap in metastatic breast cancer research and care: accurately measuring treatment response in patients with bone metastases
Cleveland Clinic presents final results of phase 1 clinical trial of preventive breast cancer vaccine study
Nationally renowned anesthesiology physician-scientist and clinical operations leader David Mintz, MD, PhD, named Chair of the Department of Anesthesiology at the UM School of Medicine
Clean water access improves child health in Mozambique, study shows
[Press-News.org] Long-term results encouraging for combination immunotherapy for advanced melanomaThe first long-term follow-up results from a phase 1b immunotherapy trial combining drugs for advanced melanoma patients has shown encouraging results